FRANKFURT--The following is a summary of analysts' forecasts for
Novartis AG (NVS) second-quarter results, based on a poll of nine
analysts conducted by Dow Jones Newswires (figures in million
dollars, EPS in dollar, target price in swiss francs, according to
IFRS). Earnings figures are scheduled to be released July 21.
===
Net sales:
2nd Quarter -total -Pharma -Diovan -Gleevec -Lucentis
AVERAGE 12,712 7,732 323 1,100 534
Prev. Year 14,637 8,199 743 1,199 619
+/- in % -13 -5.7 -57 -8.3 -14
MEDIAN 12,581 7,735 333 1,103 524
Maximum 13,094 8,052 379 1,159 582
Minimum 12,488 7,481 237 1,060 503
Amount 9 7 6 7 6
Baader-Helvea 12,579 7,619 334 1,076 523
Bernstein 12,569 7,481 332 1,106 503
Credit Suisse 12,581 -- -- -- --
Deutsche Bank 13,094 8,052 337 1,159 557
Exane BNP Paribas 12,794 7,782 -- 1,109 --
J.P. Morgan 12,488 -- -- -- --
Jefferies 12,705 7,735 317 1,086 524
UBS 12,520 7,633 237 1,060 514
Zuercher KB 13,081 7,825 379 1,103 582
Core:
-Operating -Net -Net attrib.
2nd Quarter income income profit -EPS
AVERAGE 3,603 3,119 3,126 1.31
Prev. Year 3,797 3,283 3,253 1.34
+/- in % -5.1 -5.0 -3.9 -2.4
MEDIAN 3,559 3,110 3,157 1.31
Maximum 3,874 3,236 3,216 1.36
Minimum 3,441 3,022 3,004 1.24
Amount 8 4 3 9
Baader-Helvea 3,689 -- -- 1.36
Bernstein 3,571 3,187 3,157 1.31
Credit Suisse 3,472 -- -- 1.24
Deutsche Bank 3,709 -- -- 1.35
Exane BNP Paribas 3,547 -- -- 1.32
J.P. Morgan -- -- -- 1.30
Jefferies 3,441 3,022 -- 1.25
UBS 3,522 3,236 3,216 1.34
Zuercher Kantonalbank 3,874 3,032 3,004 1.30
Target price Rating
AVERAGE 109.50 positive 6
Prev. Quarter 105.04 neutral 1
+/- in % +4.2 negative 0
MEDIAN 111.50
Maximum 115.00
Minimum 96.00
Amount 6
Baader-Helvea 110.00 Buy
Berenberg 110.00 Buy
Deutsche Bank 96.00 Hold
Exane BNP Paribas 113.00 Outperform
J.P. Morgan -- Overweight
Jefferies 113.00 Buy
UBS 115.00 Buy
===
Year-earlier figures are as reported by the company.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires